IL-6

WHO signs off on IL-6 drugs to treat severe Covid-19 cases, reigniting pricing debate
Endpoints
Wed, 07/7/21 - 10:55 am
WHO
COVID-19
IL-6
Sanofi
Kevzara
Roche
Actemra
Jury still out on IL-6 drugs in COVID-19 following preliminary trial results
Pharmaforum
Tue, 04/28/20 - 10:42 am
COVID-19
clinical trials
IL-6
Sanofi
Kevzara
Roche
Actemra